|
1
|
Taylor LP: Diagnosis, treatment, and
prognosis of glioma: Five new things. Neurology. 75 (18 Suppl
1):S28–S32. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lenting K, Verhaak R, Ter Laan M,
Wesseling P and Leenders W: Glioma: Experimental models and
reality. Acta Neuropathol. 133:263–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirst TC, Vesterinen HM, Conlin S, Egan
KJ, Antonic A, Lawson McLean A, Macleod MR, Grant R, Brennan PM,
Sena ES and Whittle IR: A systematic review and meta-analysis of
gene therapy in animal models of cerebral glioma: Why did promise
not translate to human therapy? Evid Based Preclin Med.
1:e000062014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wei Y, Chang Z, Wu C, Zhu Y, Li K and Xu
Y: Identification of potential cancer-related pseudogenes in lung
adenocarcinoma based on ceRNA hypothesis. Oncotarget.
8:59036–59047. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiao-Jie L, Ai-Mei G, Li-Juan J and Jiang
X: Pseudogene in cancer: Real functions and promising signature. J
Med Gen. 52:17–24. 2015. View Article : Google Scholar
|
|
6
|
Harrison PM, Hegyi H, Balasubramanian S,
Luscombe NM, Bertone P, Echols N, Johnson T and Gerstein M:
Molecular fossils in the human genome: Identification and analysis
of the pseudogenes in chromosomes 21 and 22. Genome Res.
12:272–280. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jingsi T, Mingyao Y and Ying L: Functional
roles of pseudogenes in cancers. Yi Chuan. 37:8–16. 2015.PubMed/NCBI
|
|
8
|
Mei D, Song H, Wang K, Lou Y, Sun W, Liu
Z, Ding X and Guo J: Up-regulation of SUMO1 pseudogene 3 (SUMO1P3)
in gastric cancer and its clinical association. Med Oncol.
30:7092013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhan Y, Liu Y, Wang C, Lin J, Chen M, Chen
X, Zhuang C, Liu L, Xu W, Zhou Q, et al: Increased expression of
SUMO1P3 predicts poor prognosis and promotes tumor growth and
metastasis in bladder cancer. Oncotarget. 7:16038–16048. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang W, Li N, Hu J and Wang L: Inhibitory
effect of RNA-mediated knockdown of zinc finger protein 91
pseudogene on pancreatic cancer cell growth and invasion. Oncol
Lett. 12:1343–1348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun M, Nie FQ, Zang C, Wang Y, Hou J, Wei
C, Li W, He X and Lu KH: The Pseudogene DUXAP8 promotes
non-small-cell lung cancer cell proliferation and invasion by
epigenetically silencing EGR1 and RHOB. Mol Ther. 25:739–751. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma HW, Xie M, Sun M, Chen TY, Jin RR, Ma
TS, Chen QN, Zhang EB, He XZ, De W and Zhang ZH: The pseudogene
derived long noncoding RNA DUXAP8 promotes gastric cancer cell
proliferation and migration via epigenetically silencing PLEKHO1
expression. Oncotarget. 8:52211–52224. 2017.PubMed/NCBI
|
|
13
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pink RC, Wicks K, Caley DP, Punch EK,
Jacobs L and Carter DR: Pseudogenes: Pseudo-functional or key
regulators in health and disease? RNA. 17:792–798. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hayashi H, Arao T, Togashi Y, Kato H,
Fujita Y, De Velasco MA, Kimura H, Matsumoto K, Tanaka K, Okamoto
I, et al: The OCT4 pseudogene POU5F1B is amplified and promotes an
aggressive phenotype in gastric cancer. Oncogene. 34:199–208. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu X, Xu Y, Shi C, Wang B, Yu X, Zou Y and
Hu T: A genome-wide comprehensively analyses of long noncoding RNA
profiling and metastasis associated lncRNAs in renal cell
carcinoma. Oncotarget. 8:87773–87781. 2017.PubMed/NCBI
|
